The dream of a lifetime will come true for a Sikeston, Missouri man on Friday.
And it involves a Corvette. In fact, several of them.
Diagnosed in May with a terminal illness, Tony Ohara mentioned to his hospice nurse that he had hoped to fulfill his lifelong dream of riding in a Corvette, but the local Southeast Missouri dealership he talked to was unable to accommodate his request.
That’s when the staff at Missouri Delta Hospice stepped in to see what they could do about making his dream come true, through the power of social media.
After Business Manager Sherry Newell posted Tony’s story on Facebook, nearly 100 Corvettes were offered in less than 24 hours, and her post was shared more than 2,400 times. That post now has 400+ comments and 21,000 shares, with the number continuing to climb.
Among the kind folks who responded was Randy Newell of the Southeast Missouri Corvette Club. The club decided to team with Missouri Delta Hospice to hold Tony’s last wish event on Friday, Aug. 17 at 6 p.m.
Newell is going to surprise Ohara at his home Friday in his Corvette. But the fun will just be getting started as they’ll then travel to Sikeston Factory Outlet Mall, where they’ll be greeted with many more Corvettes from the car club and other individuals who have been touched by his story and want to be a part of this heartwarming story. They even hope to parade through the streets of Sikeston if Tony is feeling up to it.
If you happen to be in the area Friday, the public is invited to take part, too.
Source:
kfvs12.com
Related:
Sebring Hospice Group Makes Corvette Wish Come True for Cancer Patient
Corvette Racing ‘Make a Wish’ Comes True for Boy with Cancer at the Rolex 24
Cool Doctor Arranges a Weekend Corvette Drive for Cancer Patient
-
Great gesture from caring people!! But then there is the dealership – no test rides, eh? You have to buy it to try it, like Miz Nancy and Obamacare.
Great dealership. Heartless would be a compliment. If your short on Corvettes I’ll gladly drive from Canada to help a neighbor fill a wish.
Comments are closed.